Particella
Pre-clinicalParticella, Inc. (formerly DNAlite Therapeutics) is a preclinical biotechnology company that has developed an oral lipid nanoparticle technology to deliver nucleic acids to the intestinal epithelium.
Founded
2021
Focus
Drug Delivery
About
Particella, Inc. (formerly DNAlite Therapeutics) is a preclinical biotechnology company that has developed an oral lipid nanoparticle technology to deliver nucleic acids to the intestinal epithelium.
Company Info
TypePrivate
Founded2021
LocationSan Francisco, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile